|
|
Office Locations:
|
100 Tiburon Boulevard, Suite 215
Mill Valley, CA 94941
Phone: 415-944-8123
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Founded in 2005, Aphelion Capital, LLC makes public and private investments in the medical technology industry. Its primary areas of concentration are technologies that reduce the costs of the burdened healthcare system, and health and wellness products that target the patient as the consumer. Aphelion Capital invests in medical technology companies across all stages and therapeutic areas, but strongly prefers investments in companies with low capital requirements and short time lines to market. The Fund is generally a long term investor in companies that the partners believe have superior products and strong management teams. Aphelion prefers private investments where the team can partner with the company to enhance success and value appreciation. The firm will lead $20 million syndicates, or invest as little as $50,000 on a seed company.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
